CSIMarket


Celularity Inc   (CELU)
Other Ticker:  
 
 

CELU's Operating Income Growth by Quarter and Year

Celularity Inc 's Operating Income results by quarter and year




CELU Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September 10.90 0.00 0.00 0.00
II Quarter June -1.54 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   9.36 - - -



CELU Operating Income third quarter 2021 Y/Y Growth Comment
Celularity Inc in the third quarter achieved Operating Income of $ 10.90 millions compare to Operating Loss recorded in same quarter a year ago.

According to the results reported in the third quarter, Celularity Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Celularity Inc ' s Operating Income no change of % ranks overall at the positon no. 0 in the third quarter.

Explain Operating Income growth


CELU Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Celularity Inc 's third quarter 2021 Operating Income $ 10.90 millions CELU's Income Statement
Celularity Inc 's third quarter 2020 Operating Income $ 0.00 millions Quarterly CELU's Income Statement
New: More CELU's historic Operating Income Growth >>


CELU Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Celularity Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Operating Income Comment
Improvement III. Quarter 2021where Celularity Inc published Operating Income of $ 10.90 millions could is starting point of positive performance.Celularity Inc announced in the III. Quarter 2021 Operating Income of $ 10.90 millions compare to Operating Loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Celularity Inc achieved highest sequential Operating Income growth. While Celularity Inc 's Operating Income growth quarter on quarter, overall rank is 0.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Operating Income Comment
This turnaround III. Quarter 2021where Celularity Inc posted Operating Income of $ 10.90 millions may be inception of improved business climet.Celularity Inc announced in the III. Quarter 2021 Operating Income of $ 10.90 millions compare to Operating Loss recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Celularity Inc achieved highest sequential Operating Income growth. While Celularity Inc 's Operating Income growth quarter on quarter, overall rank is 0.


Celularity Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Celularity Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Celularity Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Celularity Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Celularity Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CELU's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CELU's Competitors
Operating Income Growth for Celularity Inc 's Suppliers
Operating Income Growth for CELU's Customers

You may also want to know
CELU's Annual Growth Rates CELU's Profitability Ratios CELU's Asset Turnover Ratio CELU's Dividend Growth
CELU's Roe CELU's Valuation Ratios CELU's Financial Strength Ratios CELU's Dividend Payout Ratio
CELU's Roa CELU's Inventory Turnover Ratio CELU's Growth Rates CELU's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2021
Regional Health Properties Inc -0.32%$ -0.317 millions
Abiomed Inc -1.47%$ -1.467 millions
Integra Lifesciences Holdings Corp-1.92%$ -1.917 millions
Semler Scientific inc -5.44%$ -5.437 millions
Phibro Animal Health Corp-6.86%$ -6.859 millions
Quidel Corporation-8.48%$ -8.481 millions
Conmed Corporation-9.09%$ -9.091 millions
Quest Diagnostics Inc-9.19%$ -9.192 millions
Lemaitre Vascular Inc-9.43%$ -9.433 millions
Universal Health Services Inc -9.97%$ -9.970 millions
Amedisys Inc-10.33%$ -10.331 millions
Meridian Bioscience Inc -10.40%$ -10.397 millions
Fourth Wave Energy Inc -10.53%$ -10.525 millions
Fitlife Brands Inc -13.80%$ -13.795 millions
Fonar Corporation-13.94%$ -13.941 millions
Essa Pharma inc -14.07%$ -14.072 millions
Pro dex Inc -14.91%$ -14.913 millions
U S Physical Therapy Inc-15.06%$ -15.064 millions
Owens and Minor Inc -16.78%$ -16.780 millions
Protokinetix Incorporated-16.92%$ -16.917 millions
Steris Plc-17.53%$ -17.528 millions
Electromed Inc -18.85%$ -18.852 millions
Biodelivery Sciences International Inc -20.22%$ -20.222 millions
Alr Technologies Inc -21.93%$ -21.929 millions
Petmed Express Inc-22.77%$ -22.768 millions
Retractable Technologies inc -23.02%$ -23.019 millions
Vyne Therapeutics Inc -24.33%$ -24.328 millions
Laboratory Corporation Of America Holdings-26.76%$ -26.760 millions
Biogen Inc -26.91%$ -26.915 millions
Viemed Healthcare Inc -27.75%$ -27.748 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBRL's Profile

Stock Price

CBRL's Financials

Business Description

Fundamentals

Charts & Quotes

CBRL's News

Suppliers

CBRL's Competitors

Customers & Markets

Economic Indicators

CBRL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071